Electromedical Technologies, Inc. EMED
What this company does
Written from the business description in Electromedical Technologies, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 1 May 2024. Every sentence was checked against that document before publication.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Not applicable: equity was negative in this period, so return on equity has no meaning.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | · | · | · | · | · |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.0 | · | · | · | · |
| EPS, diluted $ | 0.00 | −0.03 | −0.24 | −0.20 | −0.10 |
| Dividend / sh $ | · | · | · | · | · |
| Payout % | · | · | · | · | · |
| ROE % | · | · | · | · | · |
| Shares out B | 0.46 | 0.19 | 0.09 | 0.03 | 0.02 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 5 of 19 fiscal years. 71 checks could not be computed.